Severe encephalopathy associated with SARS-CoV-2 Omicron BA.1 variant infection in a neonate.

Coronavirus disease 2019 (COVID-19) Encephalomalacia Neonate Omicron variant Severe encephalopathy

Journal

Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 18 04 2022
revised: 12 06 2022
accepted: 27 06 2022
pubmed: 15 7 2022
medline: 11 11 2022
entrez: 14 7 2022
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19), including the Omicron variant, is less severe in children than in adults. To date, there has been no detailed description of COVID-19-associated severe encephalopathy due to the Omicron variant during the neonatal and early infantile periods. During the outbreak of the Omicron variant, a 29-day-old male presented with a pale and ill appearance. The patient was intubated for mechanical ventilation owing to recurrent apnea, which subsequently turned out to be a breath-holding that may have been caused by seizure. In addition, nonconvulsive status epilepticus was observed. Total duration of repetitive seizure activities was approximately 30 min per hour when seizures were most severe. Brain magnetic resonance imaging (MRI) on day 14 revealed extensive hyperintensity in the T2 sequence, hypointensity in the fluid-attenuated inversion recovery (FLAIR) sequence in the deep and subcortical white matter, and diffusion restriction in the corpus callosum. The Omicron BA.1 variant of the severe acute respiratory syndrome coronavirus 2 was detected in his respiratory sample. Follow-up MRI on day 45 revealed multiple cystic cavitations. Although COVID-19 is not severe in most children, life-threatening conditions such as COVID-19-associated severe encephalopathy can occur during the neonatal and early infantile periods.

Identifiants

pubmed: 35835638
pii: S0387-7604(22)00111-5
doi: 10.1016/j.braindev.2022.06.010
pmc: PMC9273474
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

743-747

Informations de copyright

Copyright © 2022 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Mult Scler Relat Disord. 2020 Nov;46:102535
pubmed: 33010584
Transl Pediatr. 2015 Oct;4(4):283-9
pubmed: 26835390
Pediatrics. 2012 Mar;129(3):e748-55
pubmed: 22331332
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152
pubmed: 35085225
Biomed J. 2022 Feb;45(1):50-62
pubmed: 34793991
Pediatr Neurol. 2022 Mar;128:33-44
pubmed: 35066369
Clin Infect Dis. 2013 Oct;57(8):1114-28
pubmed: 23861361
Brain Dev. 2021 Oct;43(9):919-930
pubmed: 34120800
Lancet Child Adolesc Health. 2021 Mar;5(3):167-177
pubmed: 33338439
J Clin Neurophysiol. 2021 Jan 1;38(1):1-29
pubmed: 33475321
JAMA Neurol. 2021 May 1;78(5):536-547
pubmed: 33666649
Lancet Child Adolesc Health. 2021 Sep;5(9):631-641
pubmed: 34273304
Pediatr Infect Dis J. 2021 Jul 1;40(7):e270-e271
pubmed: 33902082
Rev Med Virol. 2014 Nov;24(6):407-19
pubmed: 25316031
Ann Neurol. 2021 May;89(5):872-883
pubmed: 33704826
J Pediatr. 2021 Jan;228:94-100.e3
pubmed: 32910943
BMJ. 2020 Aug 27;370:m3249
pubmed: 32960186

Auteurs

Kenichi Tetsuhara (K)

Department of Critical Care Medicine, Fukuoka Children's Hospital, Fukuoka, Japan. Electronic address: ken-tetsuhara@mti.biglobe.ne.jp.

Satoshi Akamine (S)

Department of Pediatric Neurology, Fukuoka Children's Hospital, Fukuoka, Japan.

Yoshie Matsubara (Y)

Department of Pediatric Neurology, Fukuoka Children's Hospital, Fukuoka, Japan.

Shunsuke Fujii (S)

Department of Critical Care Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.

Wataru Kashimada (W)

Department of Cardiology, Fukuoka Children's Hospital, Fukuoka, Japan.

Kentaro Marutani (K)

Department of Critical Care Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.

Michiko Torio (M)

Department of Pediatric Neurology, Fukuoka Children's Hospital, Fukuoka, Japan; Department of General Pediatrics and Interdisciplinary Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.

Yuya Morooka (Y)

Department of General Pediatrics and Interdisciplinary Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.

Nozomu Hanaoka (N)

Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan.

Tsuguto Fujimoto (T)

Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan.

Haruna Nakamura-Miwa (H)

Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.

Satoru Arai (S)

Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.

Keiko Tanaka-Taya (K)

Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.

Kenji Furuno (K)

Department of General Pediatrics and Interdisciplinary Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.

Yumi Mizuno (Y)

Department of Pediatric Infectious Disease and Immunology, Fukuoka Children's Hospital, Fukuoka, Japan.

Ryutaro Kira (R)

Department of Pediatric Neurology, Fukuoka Children's Hospital, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH